Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 20;25(1):121.
doi: 10.1186/s12872-025-04527-9.

Efficacy of sivelestat in alleviating postoperative pulmonary injury in patients with acute aortic dissection undergoing total arch replacement: a retrospective cohort study

Zhiyan Mai #  1   2 , Xudong Liu #  2 , Weixun Duan #  1 , Chen Yang  1 , Yenong Zhou  1 , Tao Chen  1 , Zheng Su  3 , Yang Yang  4 , Jincheng Liu  1 , Zhenxiao Jin  5
Affiliations

Efficacy of sivelestat in alleviating postoperative pulmonary injury in patients with acute aortic dissection undergoing total arch replacement: a retrospective cohort study

Zhiyan Mai et al. BMC Cardiovasc Disord. .

Abstract

Objective: Sivelestat may reduce postoperative pulmonary injury after total arch replacement (TAR). This study aimed to evaluate whether the preoperative PaO2/FiO2 (P/F) ratio affects the efficacy of sivelestat in reducing postoperative pulmonary injury in patients with acute aortic dissection (AAD) who underwent TAR using deep hypothermic circulatory arrest (DHCA).

Methods: Data of patients with AAD who underwent TAR using DHCA in a tertiary hospital between February 1, 2022, and December 30, 2022, were retrospectively reviewed. The patients were divided into the sivelestat and control groups. Three subgroup analyses were performed based on the postoperative P/F ratio. The primary clinical outcomes were assessed to determine the efficacy and safety of sivelestat in managing postoperative pulmonary dysfunction in patients undergoing cardiopulmonary bypass.

Results: A total of 187 patients were included, with 95 in the sivelestat group and 92 in the control group. No significant differences were found in the clinical variables between the two groups (all P > 0.05), except for some improvements in the inflammatory biomarker levels (including white blood cell count, neutrophil count, and C-reactive protein). Subgroup analysis revealed that sivelestat treatment significantly increased the P/F ratio on the 4th day and 3rd day after TAR in patients with mild lung injury (P = 0.02) and moderate lung injury (P = 0.03), respectively. Additionally, sivelestat reduced the levels of several postoperative inflammatory biomarkers in both subgroups.

Conclusions: Among patients with AAD with mild or moderate preoperative lung injury, defined by a low P/F ratio, sivelestat significantly improved the postoperative P/F ratio and attenuated inflammatory responses after TAR. These findings suggest an important avenue for further research.

Keywords: Hypothermic circulatory arrest; PaO2/FiO2 ratio; Pulmonary injury; Sivelestat; Total arch replacement.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: This was a single-center retrospective cohort study. The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethical Committee of Xijing Hospital (KY20242093-C-1). The requirement for written consent was waived owing to its retrospective nature. Competing interests: The authors declare no competing interests. Clinical trial number: Not applicable.

Figures

Fig. 1
Fig. 1
Flow chart showing the participant enrollment process
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Hagan PG, Nienaber CA, Isselbacher EM, Bruckman D, Karavite DJ, Russman PL, Evangelista A, Fattori R, Suzuki T, Oh JK, et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA. 2000;283(7):897–903. - PubMed
    1. Su IM, Huang HK, Liu PP, Hsu JY, Lin SM, Loh CH. Mortality risk from acute aortic dissection among hospital admissions during weekends and holiday season. PLoS ONE. 2021;16(9):e0255942. - PMC - PubMed
    1. Malaisrie SC, Szeto WY, Halas M, Girardi LN, Coselli JS, Sundt TM 3rd, Chen EP, Fischbein MP, Gleason TG, Okita Y, et al. 2021 the American Association for Thoracic Surgery expert consensus document: surgical treatment of acute type a aortic dissection. J Thorac Cardiovasc Surg. 2021;162(3):735–e758732. - PubMed
    1. Gao J, Yan J, Duan Y, Yu J, Li W, Luo Z, Yu W, Xie D, Liu Z, Xiong J. Aortic arch branch-prioritized reconstruction for type A aortic dissection surgery. Front Cardiovasc Med. 2023;10:1321700. - PMC - PubMed
    1. Nteliopoulos G, Nikolakopoulou Z, Chow BHN, Corless R, Nguyen B, Dimarakis I. Lung injury following cardiopulmonary bypass: a clinical update. Expert Rev Cardiovasc Ther. 2022;20(11):871–80. - PubMed

MeSH terms

LinkOut - more resources